LIVE IN- PERSON & VIRTUAL CONFERENCE
JULY 17 – 18, 2025
Venue: Universidad Católica Argentina
San José Building – Juan Pablo II Meeting Room
Av. Alicia M. de Justo 1680, Puerto Madero
Buenos Aires, Argentina
11th INTERAMERICAN ONCOLOGY CONFERENCE
HYBRID CONFERENCE
Dear Colleague
It´s our honour and pleasure to invite you to attend the 11th InterAmerican Oncology Conference on July 17-18, 2025.
The hybrid format will include a two day live program, which will be a combination of on-site and online presentations. The interactive virtual format will be available for those who may choose to participate from a distance. So you can attend the conference either on-site in Buenos Aires or virtually.
An outstanding faculty of speakers from the United States and Europe has committed to participate in this meeting. The conference agenda will focus on new translational advances in the treatment of cancer as well as provide updates of conventional therapies for a number of the most common tumor types.
The meeting objectives are designed to introduce the audience to the latest information on targeted therapies, immunotherapies, and emerging treatments in early development.
This meeting is the primary opportunity for practicing oncologists, urologists, basic clinical and translational investigators, scientists and cancer related health care workers to participate in a conference focusing on novel therapies and other treatment advances which are changing the face of cancer care.
Presentations will be translated into spanish in real time for the attendees.
We are looking forward to welcoming you.
Alex A. Adjei, MD, PH.D, FACP
Cleveland Clinic , USA
Chairman Taussig Cancer Institute - Cleveland Clinic - Cleveland, Ohio, USA
Enriqueta Felip, MD, Ph.D
Vall d’Hebron Institute of Oncology , Spain
Section in Chief, Medical Oncology Department - Vall d’Hebron University Hospital - Head, Thoracic Oncology and H&N Cancer Unit - Vall d’Hebron Institute of Oncology (VHIO) - Professor of Medicine, UVic-UCC - Vall d’Hebron Institute of Oncology - Barcelona, Spain
NATASHA LEIGHL, MD, MMSC, FRCPC, FASCO
PRINCESS MARGARET CANCER CENTRE, CANADA.
OSI PHARMACEUTICALS FOUNDATION CHAIR - PRINCESS MARGARET CANCER CENTRE- TORONTO, CANADA
